相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Microsatellite instability and immune checkpoint inhibitors: toward precision medicine against gastrointestinal and hepatobiliary cancers
Yuji Eso et al.
JOURNAL OF GASTROENTEROLOGY (2020)
Microsatellite instability status is determined by targeted sequencing with MSIcall in 25 cancer types
Yosuke Hirotsu et al.
CLINICA CHIMICA ACTA (2020)
Pembrolizumab for advanced anal squamous cell carcinoma (ASCC): Results from the multicohort, phase II KEYNOTE-158 study
Aurelien Marabelle et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Comprehensive analysis of indels in whole-genome microsatellite regions and microsatellite instability across 21 cancer types
Akihiro Fujimoto et al.
GENOME RESEARCH (2020)
Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair-Deficient Cancer: Results From the Phase II KEYNOTE-158 Study
Aurelien Marabelle et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
KRAS-IRF2 Axis Drives Immune Suppression and Immune Therapy Resistance in Colorectal Cancer
Wenting Liao et al.
CANCER CELL (2019)
Mutational Analysis of Patients With Colorectal Cancer in CALGB/SWOG 80405 Identifies New Roles of Microsatellite Instability and Tumor Mutational Burden for Patient Outcome
Federico Innocenti et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Immunotherapy in colorectal cancer: rationale, challenges and potential
Karuna Ganesh et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Tumor mutational burden is predictive of response to immune checkpoint inhibitors in MSI-high metastatic colorectal cancer
A. B. Schrock et al.
ANNALS OF ONCOLOGY (2019)
Oncogenic KRAS Drives Immune Suppression in Colorectal Cancer
Kay Hanggi et al.
CANCER CELL (2019)
WRN helicase is a synthetic lethal target in microsatellite unstable cancers
Edmond M. Chan et al.
NATURE (2019)
Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens
Fiona M. Behan et al.
NATURE (2019)
CANCER Genetic diversity of tumors with mismatch repair deficiency influences anti-PD-1 immunotherapy response
Rajarsi Mandal et al.
SCIENCE (2019)
Werner syndrome helicase is a selective vulnerability of microsatellite instability-high tumor cells
Simone Lieb et al.
ELIFE (2019)
Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer
Jakob Nikolas Kather et al.
NATURE MEDICINE (2019)
Patient-Derived Xenografts and Matched Cell Lines Identify Pharmacogenomic Vulnerabilities in Colorectal Cancer
Luca Lazzari et al.
CLINICAL CANCER RESEARCH (2019)
Noninvasive Detection of Microsatellite Instability and High Tumor Mutation Burden in Cancer Patients Treated with PD-1 Blockade
Andrew Georgiadis et al.
CLINICAL CANCER RESEARCH (2019)
An updated review of microsatellite instability in the era of next-generation sequencing and precision medicine
Hiroyuki Yamamoto et al.
SEMINARS IN ONCOLOGY (2019)
Immunopathologic Stratification of Colorectal Cancer for Checkpoint Blockade Immunotherapy
Nicolas J. Llosa et al.
CANCER IMMUNOLOGY RESEARCH (2019)
A Comprehensive PDX Gastric Cancer Collection Captures Cancer Cell-Intrinsic Transcriptional MSI Traits
Simona Corso et al.
CANCER RESEARCH (2019)
High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants
Pedram Razavi et al.
NATURE MEDICINE (2019)
Adaptive mutability of colorectal cancers in response to targeted therapies
Mariangela Russo et al.
SCIENCE (2019)
DNA Mismatch Repair Deficiency and Immune Checkpoint Inhibitors in Gastrointestinal Cancers
Juan Ruiz-Banobre et al.
GASTROENTEROLOGY (2019)
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
Jonathan J. Havel et al.
NATURE REVIEWS CANCER (2019)
Werner Syndrome Helicase Is Required for the Survival of Cancer Cells with Microsatellite Instability
Lorn Kategaya et al.
ISCIENCE (2019)
Nonsense-mediated mRNA Decay and Cancer
Maximilian W. Popp et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2018)
Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair-Deficient/Microsatellite Instability-High Metastatic Colorectal Cancer
Michael J. Overman et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Complex pattern of immune evasion in MSI colorectal cancer
Mine Ozcan et al.
ONCOIMMUNOLOGY (2018)
Targeting nonsense-mediated mRNA decay in colorectal cancers with microsatellite instability
Adem Bokhari et al.
ONCOGENESIS (2018)
MSIpred: a python package for tumor microsatellite instability classification from tumor mutation annotation data using a support vector machine
Chen Wang et al.
SCIENTIFIC REPORTS (2018)
Identification of Positively and Negatively Selected Driver Gene Mutations Associated With Colorectal Cancer With Microsatellite Instability
Vincent Jonchere et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2018)
Hypermutated tumours in the era of immunotherapy: The paradigm of personalised medicine
Laetitia Nebot-Bral et al.
EUROPEAN JOURNAL OF CANCER (2017)
Immune Activation and Benefit From Avelumab in EBV-Positive Gastric Cancer
Anshuman Panda et al.
JNCI-Journal of the National Cancer Institute (2017)
Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study
Michael J. Overman et al.
LANCET ONCOLOGY (2017)
Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with advanced colorectal carcinoma
Bert H. O'Neil et al.
PLOS ONE (2017)
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
Dung T. Le et al.
SCIENCE (2017)
Checkpoint inhibitors in endometrial cancer: preclinical rationale and clinical activity
Gloria Mittica et al.
ONCOTARGET (2017)
Immune Activation and Benefit From Avelumab in EBV-Positive Gastric Cancer
Anshuman Panda et al.
JNCI-Journal of the National Cancer Institute (2017)
MIRMMR: binary classification of microsatellite instability using methylation and mutations
Steven M. Foltz et al.
BIOINFORMATICS (2017)
CXCR2 Inhibition Profoundly Suppresses Metastases and Augments Immunotherapy in Pancreatic Ductal Adenocarcinoma
Colin W. Steele et al.
CANCER CELL (2016)
Tumor genotype and immune microenvironment in POLE-ultramutated and MSI-hypermutated Endometrial Cancers: New candidates for checkpoint blockade immunotherapy?
Piera Gargiulo et al.
CANCER TREATMENT REVIEWS (2016)
The evolving role. of microsatellite instability in colorectal cancer: A review
Fabio Gelsomino et al.
CANCER TREATMENT REVIEWS (2016)
Integrative Analyses of Colorectal Cancer Show Immunoscore Is a Stronger Predictor of Patient Survival Than Microsatellite Instability
Bernhard Mlecnik et al.
IMMUNITY (2016)
Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
Nicholas McGranahan et al.
SCIENCE (2016)
Somatic POLE proofreading domain mutation, immune response, and prognosis in colorectal cancer: a retrospective, pooled biomarker study
Enric Domingo et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2016)
Microsatellite instability: an update
Hiroyuki Yamamoto et al.
ARCHIVES OF TOXICOLOGY (2015)
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
D. T. Le et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
The Vigorous Immune Microenvironment of Microsatellite Instable Colon Cancer Is Balanced by Multiple Counter-Inhibitory Checkpoints
Nicolas J. Llosa et al.
CANCER DISCOVERY (2015)
ORAL MEDICINE Amlexanox
Vasudev Ballal et al.
BRITISH DENTAL JOURNAL (2014)
An updated review of gastric cancer in the next-generation sequencing era: Insights from bench to bedside and vice versa
Hiroyuki Yamamoto et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
CXCR2-Expressing Myeloid-Derived Suppressor Cells Are Essential to Promote Colitis-Associated Tumorigenesis
Hiroshi Katoh et al.
CANCER CELL (2013)
The Continuum of Cancer Immunosurveillance: Prognostic, Predictive, and Mechanistic Signatures
Jerome Galon et al.
IMMUNITY (2013)
Interrelationship between microsatellite instability and microRNA in gastrointestinal cancer
Hiroyuki Yamamoto et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
NMD: RNA biology meets human genetic medicine
Madhuri Bhuvanagiri et al.
BIOCHEMICAL JOURNAL (2010)
A UPF3-mediated regulatory switch that maintains RNA surveillance
Wai-Kin Chan et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2009)
Nonsense-Mediated mRNA Decay Impacts MSI-Driven Carcinogenesis and Anti-Tumor Immunity in Colorectal Cancers
Jamila El-Bchiri et al.
PLOS ONE (2008)
WRN promoter methylation possibly connects mucinous differentiation, microsatellite instability and CpG island methylator phenotype in colorectal cancer
Takako Kawasaki et al.
MODERN PATHOLOGY (2008)
Carcinogenesis and microsatellite instability: the interrelationship between genetics and epigenetics
Kohzoh Imai et al.
CARCINOGENESIS (2008)
Characterization of the immune escape phenotype of human gastric cancers with and without high-frequency microsatellite instability
T. Hirata et al.
JOURNAL OF PATHOLOGY (2007)
Differential nonsense mediated decay of mutated mRNAs in mismatch repair deficient colorectal cancers
J El-Bchiri et al.
HUMAN MOLECULAR GENETICS (2005)
Inhibition of nonsense-mediated mRNA decay rescues the phenotype in Ullrich's disease
F Usuki et al.
ANNALS OF NEUROLOGY (2004)
分享论文
